These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30805710)

  • 21. Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons.
    Gisina A; Kim Y; Yarygin K; Lupatov A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
    Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
    Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced tumorigenesis and lymphatic metastasis of CD133+ hepatocarcinoma ascites syngeneic cell lines mediated by JNK signaling pathway in vitro and in vivo.
    Jin Y; Mao J; Wang H; Hou Z; Ma W; Zhang J; Wang B; Huang Y; Zang S; Tang J; Li L
    Biomed Pharmacother; 2013 May; 67(4):337-45. PubMed ID: 23582787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-Expression of LGR5 and CD133 Cancer Stem Cell Predicts a Poor Prognosis in Patients With Gastric Cancer.
    Wattanawongdon W; Bathpho TS; Tongtawee T
    Turk J Gastroenterol; 2021 Mar; 32(3):261-268. PubMed ID: 34160355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxytetracycline have the therapeutic efficiency in CD133
    Song Y; Kim IK; Choi I; Kim SH; Seo HR
    Sci Rep; 2018 Oct; 8(1):16100. PubMed ID: 30382122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.
    Li Z; Yanfang W; Li J; Jiang P; Peng T; Chen K; Zhao X; Zhang Y; Zhen P; Zhu J; Li X
    Cancer Lett; 2018 Sep; 432():237-250. PubMed ID: 29709702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
    Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP
    Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma.
    Korn P; Kampmann A; Spalthoff S; Jehn P; Tavassol F; Lentge F; Gellrich NC; Zimmerer R
    Asian Pac J Cancer Prev; 2021 May; 22(5):1591-1597. PubMed ID: 34048190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
    Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
    Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation.
    Hong SW; Hur W; Choi JE; Kim JH; Hwang D; Yoon SK
    Oncotarget; 2016 Apr; 7(17):23482-97. PubMed ID: 26993601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
    Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
    Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
    Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
    Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative proteomic analysis identifies exosomal Eps8 protein as a potential metastatic biomarker for pancreatic cancer.
    Ohshima K; Hatakeyama K; Kanto K; Ide T; Watanabe Y; Moromizato S; Wakabayashi-Nakao K; Sakura N; Yamaguchi K; Mochizuki T
    Oncol Rep; 2019 Feb; 41(2):1019-1034. PubMed ID: 30431134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
    Lu RQ; Wu JG; Zhou GC; Jiang HG; Yu JW; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):174-9. PubMed ID: 22368028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
    Kim YJ; Lee HS; Jung DE; Kim JM; Song SY
    J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27891685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer.
    Lux A; Kahlert C; Grützmann R; Pilarsky C
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells.
    Lehnus KS; Donovan LK; Huang X; Zhao N; Warr TJ; Pilkington GJ; An Q
    Int J Oncol; 2013 Mar; 42(3):1011-7. PubMed ID: 23340741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of Lipid Raft Proteins from CD133+ Cancer Stem Cells.
    Gupta VK; Banerjee S
    Methods Mol Biol; 2017; 1609():25-31. PubMed ID: 28660570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
    Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
    Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.